Safety aspects in the manufacturing of plasma-derived coagulation factor concentrates

This publication has 42 references indexed in Scilit:

• Chromatographic Preparation of a Therapeutic Highly Purified von Willebrand Factor Concentrate from Human Cryoprecipitate
  Vox Sanguinis, 1992
• Detection of HIV-1 RNA in factor VIII concentrate
  AIDS, 1991
• Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates¹
  Vox Sanguinis, 1990
• Inhibitors to monoclonal antibody purified factor VIII
  The Lancet, 1990
• Thermal Inactivation by Sequential Dry‐Heat Treatments at Sterilizing Temperatures (100°C‐Boiling) of Factor VIII and Factor IX Concentrates to Produce Sterile Concentrates
  Vox Sanguinis, 1989
• Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous Transfusions
  New England Journal of Medicine, 1987
• Chromatographic removal of hepatitis B virus from a factor IX concentrate. Experimental studies in chimpanzees
  Transfusion, 1987
• Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinations
  Transfusion, 1985
• TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATES
  The Lancet, 1983
• Acute Hepatitis Non-A, Non-B following Administration of Factor VIII Concentrates
  Vox Sanguinis, 1981